Merz Pharma Group announced that it has started a tender offer for all outstanding shares of common stock of BioForm Medical, Inc. (BFRM) for $5.45 per share, net to the seller in cash, without interest and less any required withholding tax.
The tender offer is being made by Vine Acquisition Corp., an indirect wholly-owned subsidiary of Merz GmbH & Co. KGaA, in connection with the agreement and plan of merger among Merz, Vine Acquisition Corp. and BioForm Medical, announced on January 4, 2010, and pursuant to an Offer to Purchase dated January 15, 2010.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.